SCHEMBL23901725

SCHEMBL23901725

CO/N=C(\N)c1ccc(ON)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 8/20 0.49
MAPT P10636 5/20 0.49
KMT2A Q03164 2/20 0.49
GAA P10253 1/20 0.49
NPC1 O15118 9/20 0.46
RAB9A P51151 9/20 0.46
CDK5 Q00535 1/20 0.46
CDK5R1 Q15078 1/20 0.46
CASP3 P42574 3/20 0.46
SENP8 Q96LD8 3/20 0.46
SENP7 Q9BQF6 3/20 0.46
SENP6 Q9GZR1 3/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
TDP1 Q9NUW8 2/20 0.45
THRB P10828 1/20 0.45
ATM Q13315 1/20 0.45
ALDH1A1 P00352 2/20 0.43
POLB P06746 2/20 0.42
LMNA P02545 1/20 0.42
GLA P06280 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974042 0.81 NPC1 (0.42) L3MBTL1MAPTKMT2AGAANPC1
SCHEMBL13882951 0.79 SMN1; SMN2 (0.54) L3MBTL1MAPTKMT2ANPC1RAB9A
SCHEMBL14902858 0.79 SMN1; SMN2 (0.54) L3MBTL1MAPTKMT2ANPC1RAB9A
SCHEMBL6650000 0.79 MASP2 (0.43) L3MBTL1MAPTKMT2AGAANPC1
SCHEMBL6007355 0.78 NPC1 (0.58) L3MBTL1MAPTKMT2ANPC1RAB9A
SCHEMBL18615326 0.77 GAA (0.56) L3MBTL1MAPTKMT2AGAANPC1
SCHEMBL4722868 0.77 NPC1 (0.54) L3MBTL1MAPTKMT2AGAANPC1
SCHEMBL4722865 0.77 NPC1 (0.54) L3MBTL1MAPTKMT2AGAANPC1
SCHEMBL13979658 0.74 LOXL2 (0.52) L3MBTL1MAPTKMT2AGAANPC1
SCHEMBL20880149 0.74 SMN1; SMN2 (0.52) L3MBTL1MAPTKMT2AGAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210309641-A1 AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2021-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210309641-A1 AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS PAM, AMPD1, AMPD3 L3MBTL1 384/4885MAPT 4279/4885KMT2A 4413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.